Comments
Loading...

Halozyme Therapeutics

HALONASDAQ
Logo brought to you by Benzinga Data
$50.57
-0.02-0.04%
At close: -
$56.90
6.3312.52%
After Hours: 6:16 PM EDT
15 minutes delayed
Q3 2024 earnings were released today after the market close
Today's conference call ended over 6 hours ago Click to view the webcast
62.5%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
40
0100

Halozyme Therapeutics (NASDAQ:HALO) Stock Quotes, Forecast and News Summary

Halozyme Therapeutics Stock (NASDAQ: HALO) stock price, news, charts, stock research, profile.

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jul
2
Aug
1
Sep
1
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$50.56
Close$50.57
Volume / Avg.1.91M / 1.32M
Day Range$50.01 - $51.21
52 Wk Range33.07 - 65.53
Market Cap$7.21B
P/E Ratio19.61
Dividend Yield-
ExchangeNASDAQ
RSI
59
Short Interest
11.14%
Days to Cover6.34

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HALO
LEGN

FAQ

Q

How do I buy Halozyme Therapeutics (HALO) stock?

A

You can purchase shares of Halozyme Therapeutics (NASDAQ:HALO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Halozyme Therapeutics (HALO) competitors?

Q

What is the forecast, or price target, for Halozyme Therapeutics (HALO) stock?

A

Halozyme Therapeutics has a consensus price target of $57.14.

Q

What is the current price for Halozyme Therapeutics (HALO)?

A

The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $56.5 last updated October 31, 2024 at 6:33 PM EDT.

Q

Does Halozyme Therapeutics (HALO) pay a dividend?

A

There are no upcoming dividends for Halozyme Therapeutics.

Q

When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?

A

Halozyme Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Q

Is Halozyme Therapeutics (HALO) going to split?

A

There is no upcoming split for Halozyme Therapeutics.

Q

What sector and industry does Halozyme Therapeutics (HALO) operate in?

A

Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch